PRNewswire

Zhubei [Taiwan], April 17: Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially initiated IPO advisory services with First Securities Inc., which represents a key move towards entering the capital market and fostering its long-term expansion within the surgical robotics sector.

Established in 2015 within the premises of the Hsinchu Biomedical Science Park, Brain Navi specializes in developing cutting-edge surgical robots and medical equipment. The firm combines machine vision, AI, and sophisticated navigation systems to offer precise surgical solutions designed for contemporary health care demands. Throughout its history, Brain Navi has forged robust alliances with premier hospitals across the globe. These collaborations have resulted in numerous international patents and certifications from various authorities. Currently, the company is expanding into markets such as Europe, Asia, and Latin America, with plans to enter the U.S. market shortly.

The leading offering of this firm is NaoTrac, an advanced neurosurgery navigation robot that integrates artificial intelligence, robotics, and computer vision technology to boost surgical accuracy and cut down operation duration. Additionally, Brain Navi offers KrystoLens—a disposable neuro-endoscope aimed at increasing both security and effectiveness during less-invasive brain procedures.

In the future, Brain Navi intends to strengthen partnerships with leading medical institutions to enhance its smart surgical technologies. Throughout this IPO advisory phase, the firm seeks to prudently speed up research and development as well as expand its creations for wider application. clinical adoption , strengthening its role as a forefront leader in smart medical technology.

First Securities Inc. showed faith in the future growth of Brain Navi. With growing worldwide interest in surgical robotics As these technologies continue to advance—particularly in fields like neurosurgery, where precision is paramount—tools that integrate navigation with artificial intelligence are set to make a significant impact. The company will offer ongoing support during Brain Navi’s initial public offering process, assisting in bringing fresh investment prospects to those envisioning the future of smart medical care.

(ADVERTISEMENT DISCLOSURE: The aforementioned press release has been supplied by PRNewswire ANI shall not bear any responsibility whatsoever for the content thereof.